Anti-ADAM9 (Imgc936) | Read Reviews & Product Use Citations

Anti-ADAM9 (Imgc936) is a humanized antibody targeting the ADAM metallopeptidase domain 9 (ADAM9). It is a therapeutic candidate for the treatment of various cancers including non-small cell lung, pancreatic, gastric, breast, ovarian, and colorectal cancer. MW :147.66 KD.

Purity & Quality Control

Batch: A317101 Purity: 99% Protein concentration: 6.98mg/ml Endotoxin Level: ＜1EU/mg

99

Biological Activity

Description	Anti-ADAM9 (Imgc936) is a humanized antibody targeting the ADAM metallopeptidase domain 9 (ADAM9). It is a therapeutic candidate for the treatment of various cancers including non-small cell lung, pancreatic, gastric, breast, ovarian, and colorectal cancer. MW :147.66 KD.

References
[1] Scribner JA, et al. Mol Cancer Ther. 2022 Jul 5;21(7):1047-1059.

References

[1] Scribner JA, et al. Mol Cancer Ther. 2022 Jul 5;21(7):1047-1059.

Product Details

CAS No.	2642078-62-2
Isotype	Human IgG1
Source	CHO
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field